ClearBridge LLC (Maryland)’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

ClearBridge LLC (Maryland)’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-268	Closed	-$26K	–	199
2015 Q3	$26K	Hold	268	–	–	﹤0.01%	175
2015 Q2	$41K	Buy	+268	New	+$44.3K	﹤0.01%	182

Other funds holding KDNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

ClearBridge LLC (Maryland)'s KDNY Position: Q4 2015 in Review

ClearBridge LLC (Maryland) sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2015, closing a stake of 268 shares — an estimated $26K sold.

ClearBridge LLC (Maryland) first reported a position in KDNY in Q2 2015 and held it in 2 quarters. The position peaked at $41K in Q2 2015. 87 funds tracked by Wall St. Rank hold KDNY as of Q4 2015.

ClearBridge LLC (Maryland) reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
ClearBridge LLC (Maryland) sold 268 Chinook Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $26K.
ClearBridge LLC (Maryland) first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 2 quarters.
ClearBridge LLC (Maryland)'s Chinook Therapeutics, Inc. Common Stock position peaked at $41K in Q2 2015.
87 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2015.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q4 2015, filed 16 Feb 2016.